|
![]() |
AltaceThis page contains recent news articles, when available, and an overview of Altace but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Altace (when available) Ramipril is an angiotensin-converting enzyme (ACE) inhibitor similar to benazepril, fosinopril, and quinapril. An inactive prodrug, ramipril is converted to ramiprilat in the liver and is used to treat hypertension and heart failure, to reduce proteinuria and renal disease in patients with nephropathies, and to prevent stroke, myocardial infarction, and cardiac death in high-risk patients. Indicated for diuretics and digitalis in congestive heart failure as adjunctive therapy; prophylaxis in post MI. Mechanism Of Action: Ramiprilat, the active metabolite, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and an increase in plasma renin. Ramiprilat may also act on kininase II, an enzyme identical to ACE that degrades the vasodilator bradykinin. News Articles on Ramipril King Pharma 2Q Net Falls 6.9%; Alpharma Deal Credited >KG - Aug 6, 2009 Branded-pharmaceutical sales dropped 13% amid continued sales evaporation of Altace. Revenue slumped after King lost a patent case in late 2007. Wall Street Journal Drug stocks join broader market rally; King up second day - Aug 7, 2009 On Thursday, King said that its second-quarter profit fell, due largely to generic competition for Altace, one of its best-selling products. MarketWatch US HOT STOCKS: Chiquita, CBS, Crox Active In Late Trading - Aug 6, 2009 ...results beat analysts' estimates, as generic versions of the company's formerly best-selling Altace blood-pressure treatment continued to hurt sales. Wall Street Journal King's Embeda Cleared as Abuse-Resistant Painkiller - Aug 13, 2009 ...as investors wait for new products to replace revenue lost when its former top-selling heart pill Altace went generic in late 2007. Bloomberg King Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript - Aug 7, 2009 Total selling, general and administrative expense excluding special items and our co-promotion fee for Altace was $119 million in the second quarter of 2009 Seeking Alpha BUYINS.NET: (WYE) SqueezeTrigger Price is $48.060. There is ... - Aug 28, 2009 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release) AIG, HIG, GNW, CSIQ, HSNI, KG, CHUX, VITA Popular Stocks - Aug 6, 2009 ...results beat analysts' estimates, as generic versions of the company's formerly best-selling Altace blood-pressure treatment continued to hurt sales. Ub News æ²™å?¦ç±»è?¯ç‰©é”€å”®å‡?å°‘70亿美元 é?¢ä¸´è¢«ä»¿ä¹‹ç—› - Aug 4, 2009 ...是将阿é½?æ²™å?¦æˆ–其与氯噻酮组æˆ?çš„å¤?方制剂和其他诸如代文和奥美沙å?¦é…¯ä¹‹ç±»çš„æ²™å?¦ç±»è?¯ç‰©å’Œè¯¸å¦‚辉瑞的络活喜(Norvasc)和国王制è?¯çš„雷米普利(Altace)ç‰è¿›è¡Œæ¯”较。 中国食品商务网 King Pharmaceuticals legt Zahlen für das zweite Quartal vor - Aug 6, 2009 Im Pharmasegment hatte der Konzern nach wie vor unter Generika-Konkurrenz für sein Bluthochdruckmittel Altace zu leiden und verzeichnete hier einen AktienCheck Buy cheap Altace Information , side effects, online pills - Jun 30, 2009 Altace is in a group of drugs called ACE inhibitors. ACE stands for angiotensin converting enzyme. Altace is used to treat high blood pressure На плувка и дъно WhisperfromWallStreet.com Afternoon Stock Report - KG - King - Jul 9, 2009 ...acute care products that comprise Bicillin and Intal; and legacy products consisting of Altace, Levoxyl, and Cytomel to general/family practitioners, TransWorldNews (press release) Watson Pharmaceuticals to purchase Arrow Group - Jun 18, 2009 The company sells a generic version of the blood pressure drug Altace and is among the generic drug makers challenging AstraZeneca's patent on the asthma The Star-Ledger - NJ.com Shop around before you buy generic drugs - Jun 23, 2009 The generic version of Altace costs $167.89 at Walgreen's but at Costco we pay only $17.45.That's a savings of $150. Accupril's generic version costs $84.59 abc13.com Painkillers are 'safe and effective' - Jun 26, 2009 ...the company has recently recorded a first quarter loss after struggling with generic competition for one of its biggest selling drugs Altace. Hays Pharma tramadol 50 mg tablets - Jun 23, 2009 Interaction Paxil Altace Hospitality till the following tramadol 50 mg tablets letter, the ring, and then it was that edward would not interest. Glace Bay Gleaner BUYINS.NET: BLUD, NVO, RBN, ROS, SNY, CPII. Abnormal Price ... - Jun 26, 2009 Its primary medicines include Lovenox/Clexane, Plavix/Iscover, Aprovel/Avapro/Karvea, Tritace/Triatec/Delix/Altace, Lantus, Amaryl/Amarel/Solosa, Acomplia, Trading Markets (press release) SNY-A Sanofi Safety Scare? - Jun 26, 2009 Its primary medicines include Lovenox/Clexane, Plavix/Iscover, Aprovel/Avapro/Karvea, Tritace/Triatec/Delix/Altace, Lantus, Amaryl/Amarel/Solosa, Acomplia, TransWorldNews (press release) King Pharmaceuticals Inc. - Jul 6, 2009 ...acute care products that comprise Bicillin and Intal; and legacy products consisting of Altace, Levoxyl, and Cytomel to general/family practitioners, TransWorldNews (press release) Watson将以17.5亿美元收è´Arrow Group - Jun 17, 2009 Watson首叿‰§è¡Œå®˜ä¿?罗·比è?¨ç½—(Paul Bisaro)表示,Arrow还出售é™?血压è?¯ç‰©Altace(å?ˆå??ramipril)的一个仿制版本。æ¤å¤–,Arrow还是对阿斯利康公å?¸(AZN)哮喘è?¯ç‰©Pulmicortçš„ 新浪网 ווטסון תרכוש ×?ת ×™×¦×¨× ×™×ª התרופות ×”×’× ×¨×™×•×ª ×?רו גרופ - תמורת 1.7 ... - Jun 18, 2009 ...×?רו מוכרת ×’×? ×?ת הגרסה ×”×’× ×¨×™×ª לתרופה להורדת לחץ הד×? Altace, כך לפי ×ž× ×›"ל ווטסון פול ביס×?רו. לדבריו, ווטסון עושה עסקי×? רק ב×?רצות הברית, ×?בל ×?רו ×’×? משווקת כלכליסט Watson將以17.5億美元收購Arrow Group - Jun 17, 2009 Watson首å¸åŸ·è¡Œå®˜ä¿?羅·比薩羅(Paul Bisaro)表示,Arrow還出售é™?血壓藥物Altace(å?ˆå??ramipril)的一個仿制版本。æ¤å¤–,Arrow還是å°?阿斯利康公å?¸(AZN)哮喘藥物Pulmicortçš„ 新浪網 最具潜力å??大新è?¯ - Jun 17, 2009 ...æ¤å¤–国王于2007å¹´12月失去雷米普利(Altace)ä¿?护以å?Šç¾Žä»–沙酮(Skelaxin)é?¢ä¸´é?žä¸“利è?¯ç‰©å?¯èƒ½çš„å¸‚åœºå‡†å…¥ï¼Œä½¿å¾—å›½çŽ‹æ›´åŠ ä¾?赖这些新产å“?的批准。 生物通 Patient in quandary whether to take hormone - Apr 18, 2009 Brand names of some of these drugs are Lotensin, Capoten, Vasotec, Monopril, Zestril, Univasc, Aceon, Accupril, Altace and Mavik. Cough is one of their side SouthCoastToday.com FDA Safety Changes: Luvox, Altace, Capozide, Monopril, Furadantin - Apr 8, 2009 Updated monographs include those for ramipril tablets and capsules (Altace, King Pharmaceuticals, Inc), captopril plus hydrochlorothiazide tablets (Capozide Medscape King Reports Fourth-Quarter Loss on Alpharma Purchase - Feb 26, 2009 Loss of patent protection for the blood-pressure pill Altace in late 2007 led King to shift its focus to neuroscience. The company formed two partnerships Bloomberg Ranbaxy gets US FDA nod for cardiovascular drugs - Mar 8, 2009 Ramipril, which can also be used for treating hypertension, is a bioequivalent to King Pharmaceuticals' Altace drug. The drug will be available in the Hindu Seeking Gain From Pain - Mar 3, 2009 First, patent expiration is crushing sales of King's former best-seller, the hypertension medication Altace, which has fallen from $646 million in 2007 Motley Fool Closing Bell - Mar 9, 2009 The US FDA determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference listed drug, Altace, Economic Times Janssen reps sue, alleging off-label Risperdal push; MannKind to ... - Mar 9, 2009 Release > Ranbaxy Laboratories got final FDA approval to sell its version of the King Pharmaceuticals cardiovascular drug Altace, the third approval for FiercePharma Novartis says strong dollar to weaken earnings; Biovail founder ... - Feb 26, 2009 ...largely due to the costs of acquiring rival Alpharma, but also because its Altace painkiller went off patent a year ago, causing sales to drop. FiercePharma Weis Markets Expands Low-Cost Prescription Plan - Feb 19, 2009 ...cholesterol, diabetes, infections and digestive ailments and the new generic drug Altace, which is used to treat high blood pressure and heart failure. PR Newswire (press release) King Pharmaceuticals muss Verlust ausweisen - Feb 26, 2009 Der Umsatzrückgang resultierte dabei vor allem aus zuletzt durch Konkurrenten vertriebene Generika-Versionen des Bluthochdruck-Medikaments Altace. Stock World King Pharmaceuticals Cuts 22% of Work Force - Feb 3, 2009 Since it lost a 2007 patent case involving its once top-selling Altace blood-pressure drug, King had shifted its focus onto other products, Wall Street Journal King Pharmaceuticals to lay off 70 at Bristol headquarters - Jan 30, 2009 King went through a similar downsizing in late 2007 — cutting 20 percent of its work force — when patents on its branded hypertension drug Altace led to its Kingsport Times News, King Pharmaceuticals plans to appeal loss of patent for Skelaxin - Jan 21, 2009 King, which employs about 500 people at its Bristol headquarters, survived an even bigger hit in September 2007 when its hypertension drug Altace went Kingsport Times News, Free ringtones tmobile - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace free ringtones tmobile generic ciales going the free ringtones tmobile at about Griggs County Courier, Doxycycline purchase - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace doxycycline purchase generic ciales going the doxycycline purchase at about Griggs County Courier, Buy androgel - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace buy androgel generic ciales going the buy androgel at about information. Griggs County Courier, Oxycodone pills - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace oxycodone pills generic ciales going the oxycodone pills at about information. Griggs County Courier, Blood pressure medicine can cause hacking cough - Dec 22, 2008 Like other blood pressure drugs in this class (Accupril, Altace, benazepril, captopril, enalapril, ramipril and quinapril), lisinopril can cause a hacking Los Angeles Times, Medicine triggers hallucinations - Dec 22, 2008 Like other blood pressure drugs in this class (Accupril, Altace, benazepril, captopril, enalapril, ramipril and quinapril), lisinopril can cause cough as an Online Athens, Pain Therapeutics, King Fall as Drug to Thwart Abuse Is Delayed - Dec 11, 2008 King is under pressure from investors to introduce new drugs to replace revenue lost after its top-selling heart pill Altace went generic last year, Bloomberg December 2008 Mayo Clinic Health Letter Highlights: Colorectal ... - Dec 9, 2008 Altace (ramipril) for blood pressure and heart failure -- Ambien (zolpidem), a sleep aid -- Depakote (divalproex) for seizures, migraines and bipolar MarketWatch Sanofi-Aventis : un nouveau site à Floirac - Dec 15, 2008 Lantus, Copaxone, Aprovel, Avapro, Karvea, Tritace, Triatec, Delix, Altace, Allegra, Telfast, Amaryl, Amarel, Solosa, Xatral, Actonel, Dépakine. Échos Judiciaires Girondins, Pharma company poised to introduce new drug therapies - Sep 24, 2008 Driving the decline was a drop in sales of Altace of nearly $120 million. Although King announced a 20% reduction in the US salesforce following the adverse Stockhouse, Alpharma rejects King Pharma's $37 per share sweetened offer - Update - Sep 26, 2008 The proposal comes, as King Pharma is trying to reposition itself, as generic competition eroded sales of its best-selling blood pressure drug Altace. Trading Markets (press release), Weis Markets Completes Rollout of New 90-Day $9.99 Prescription ... - Oct 3, 2008 Weis Markets' 90-Day Prescription plan includes the new generic drug Altace, which is used to treat high blood pressure and heart failure. SYS-CON Media, [계ì˜?ê·œ 칼럼]걷기와 소ì‹?(å°?食)ì?˜ 기ì ? - Sep 28, 2008 ...그러다 7 ë…„ ì „ë¶€í„°ëŠ” 혈압까지 ì •ìƒ?치 보다 높다 하여 혈압 약(Altace 5mg)까지 매ì?¼ 한 알씩 추가로 복용 하게 ë?˜ì—ˆë‹¤. ê²°êµ ì•½ë¬¼ë§Œìœ¼ë¡œëŠ” 병ì?´ 났기는 커녕 세월ì?´ ìº?나다 ë°´ì¿ ë²„ 중앙ì?¼ë³´, There are a number of ways to fight restless legs Sep 13, 2008 ACE inhibitors include Vasotec, enalapril, captopril, Accupril, Altace and Mavik. If you are not sure about your medicine's safety with potassium,SouthCoastToday.com, King's Unstoppable Urge to Merge Sep 12, 2008 Hypertension treatment Altace has begun to face generic competition, and muscle relaxant Skelaxin will face generic competition sooner than expected.Motley Fool Market Likes Alpharma’s Rejection of King’s Rich Offer Aug 22, 2008 Last year, the company lost a patent lawsuit over its best-selling blood-pressure drug Altace. Earlier this month, the company said its second-quarter netWall Street Journal Blogs, Alpharma reports positive Embeda pain drug data Sep 9, 2008 King is eager to expand its presence in the pain drug market as sales of its blood pressure drug Altace reel from the impact of generic rivals.guardian.co.uk, Understanding hypertension Aug 18, 2008 We have medicines that inhibit the action of the kidney (such as Altace and Enalapril) and that block the places on the muscle where the hormone attachesStaten Island Advance - SILive.com, Throat and Tongue Swelling Can Be Lethal Aug 17, 2008 Lotensin, captopril, Vasotec, Lisinopril, Prinivil, Monopril, Zestril, Accupril, Altace and Mavik are examples. Other medicines involved in angioedema areRedOrbit, King Pharma offers $33 a share for Alpharma Aug 22, 2008 The proposal comes, as King Pharma is trying to reposition itself, as generic competition eroded sales of its best-selling blood pressure drug Altace.Trading Markets (press release), Pfizer may take over King Pharmaceuticals, analysts say - 06 Aug 2008 Pfizer may acquire King Pharmaceuticals, maker of the blood-pressure drug Altace, some analysts said. Representatives for both companies declined to comment SmartBrief, King Options Surge on Takeover Rumors - Aug 5, 2008 The firm makes money on its Altace blood-pressure pills, but recently shifted its focus to painkillers after its patent was taken away. LEAPSInvestor.com, Would Pfizer Buy King Pharmaceuticals? - Aug 5, 2008 King, which sells the Altace blood-pressure pill, shifted its focus to painkillers after a court ruling invalidated the drug’s patent last fall, Pharmalot, Lupin net up 101% at Rs 112 crore - Jul 22, 2008 King Pharmaceutical's branded product of Ramipril - Altace capsules, had an annual sales of $ 920 million in 2007. Lupin's advanced markets formulation Business Standard, Pharma Q1 show to stay robust - Jul 16, 2008 King Pharmaceutical's branded ramipril product, Altace, had sales of $920 million in 2007. Ranbaxy Laboratories, Glenmark, Zydus Cadila and Aurobindo are Business Standard, Gannon On Investing's July 2008 Blogger Roundtable - Jul 21, 2008 The stock got hammered, primarily because it lost patent protection for its largest drug (a heart drug called Altace) in 2007. King's strategy is to acquire Seeking Alpha, BUYINS.NET: (WYE) SqueezeTrigger Price is $44.892. There is ... - Jul 23, 2008 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release), Fundasalud registró 8.539 sucrenses con hipertensión - Jul 26, 2008 Los fármacos prescritos a los hipertensos son el Norvasc, Coraspirina, Lanicor y Altace, entre otros. Para recibir tratamiento contra la hipertensión, El Tiempo de Venezuela, Brand Names/Synonyms: Altace is also known by the following brand names and/or synonymsAcovil; Altace; Carasel; Cardace; Delix; HOE 498; Hytren; Lostapres; Pramace; Quark; Ramace; Ramipril; Ramipril [Usan:Ban:Inn]; Ramiprilum [Latin]; Triatec; Tritace; Unipril; Vesdil Drug Category: Altace is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA05 Dosage Forms: CAPSULE Absorption: The extent of absorption is at least 50-60% and is not significantly influenced by the presence of food in the GI tract, although the rate of absorption is reduced. Interactions: Interactions for Ramipril: With nonsteroidal anti-inflammatory agents: Rarely, concomitant treatment with ACE inhibitors and nonsteroidal anti-inflammatory agents have been associated with worsening of renal failure and an increase in serum potassium. With Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ramipril. The possibility of hypotensive effects with ramipril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ramipril. If this is not possible, the starting dose should be reduced. With Potassium Supplements and Potassium-sparing Diuretics: Ramipril can attenuate potassium loss caused by thiazide diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored frequently. With Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. If a diuretic is also used, the risk of lithium toxicity may be increased. Other: Neither ramipril nor its metabolites have been found to interact with food, digoxin, antacid, furosemide, cimetidine, indomethacin, and simvastatin. The combination of ramipril and propranolol showed no adverse effects on dynamic parameters (blood pressure and heart rate). The co-administration of ramipril and warfarin did not adversely affect the anticoagulant effects of the latter drug. Additionally, co-administration of ramipril with phenprocoumon did not affect minimum phenprocoumon levels or interfere with the subjects' state of anti-coagulation. Chemical IUPAC Name: 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-4-azabicyclo[3.3.0]octane-3-carboxylicacid : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |